This year may indeed be the year in which a class of immunotherapeutics called PD-1 and PD-L1 inhibitors are approved for a variety of cancers, as forecast recently by Drew Pardoll, MD, PhD, in a blog post. There is huge excitement surrounding these drugs because patients with nume ...
Apr 30, 2015
The Food and Drug Administration says Medtronic must stop most sales of its implantable drug pumps after years of uncorrected problems.
Apr 27, 2015